Bank Julius Baer & Co. Ltd Zurich Sells 841 Shares of Cardinal Health, Inc. (NYSE:CAH)

Bank Julius Baer & Co. Ltd Zurich reduced its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 13.0% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 5,612 shares of the company’s stock after selling 841 shares during the quarter. Bank Julius Baer & Co. Ltd Zurich’s holdings in Cardinal Health were worth $664,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of the business. Fiera Capital Corp bought a new stake in shares of Cardinal Health during the third quarter worth $507,000. Assetmark Inc. grew its position in Cardinal Health by 25.8% during the 3rd quarter. Assetmark Inc. now owns 37,561 shares of the company’s stock worth $4,151,000 after acquiring an additional 7,692 shares during the last quarter. Atria Investments Inc increased its holdings in Cardinal Health by 7.5% in the 3rd quarter. Atria Investments Inc now owns 12,810 shares of the company’s stock worth $1,416,000 after purchasing an additional 899 shares in the last quarter. Sigma Planning Corp raised its position in Cardinal Health by 20.2% in the third quarter. Sigma Planning Corp now owns 11,431 shares of the company’s stock valued at $1,263,000 after purchasing an additional 1,924 shares during the last quarter. Finally, Addison Advisors LLC acquired a new stake in shares of Cardinal Health during the third quarter valued at about $281,000. 87.17% of the stock is owned by institutional investors and hedge funds.

Cardinal Health Trading Down 1.9 %

Shares of CAH opened at $124.07 on Tuesday. The stock has a 50 day moving average of $125.70 and a 200 day moving average of $118.98. The company has a market capitalization of $29.97 billion, a price-to-earnings ratio of 23.15, a PEG ratio of 1.49 and a beta of 0.66. Cardinal Health, Inc. has a 12 month low of $93.17 and a 12 month high of $132.84.

Cardinal Health (NYSE:CAH) last announced its earnings results on Thursday, January 30th. The company reported $1.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. As a group, equities research analysts predict that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be given a dividend of $0.5056 per share. This represents a $2.02 dividend on an annualized basis and a dividend yield of 1.63%. The ex-dividend date of this dividend is Tuesday, April 1st. Cardinal Health’s dividend payout ratio is currently 37.69%.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on the stock. Bank of America upgraded shares of Cardinal Health from a “neutral” rating to a “buy” rating and raised their price objective for the company from $132.00 to $145.00 in a report on Monday, January 6th. Mizuho assumed coverage on shares of Cardinal Health in a research note on Wednesday, December 4th. They set an “outperform” rating and a $139.00 price target for the company. Citigroup boosted their price objective on shares of Cardinal Health from $120.00 to $129.00 and gave the stock a “neutral” rating in a research note on Friday, January 10th. Evercore ISI upgraded Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 price target on the stock in a research report on Tuesday, January 7th. Finally, Jefferies Financial Group raised Cardinal Health from a “hold” rating to a “buy” rating and increased their price target for the company from $140.00 to $150.00 in a research note on Wednesday, February 5th. Four investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. Based on data from MarketBeat, Cardinal Health currently has an average rating of “Moderate Buy” and an average price target of $139.36.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.